In a recent review published in the journal Obesity Pillars , a team of researchers collate and narratively review the literature on the dietary impacts of obesity or type 2 diabetes (T2D) patients undergoing glucagon-like peptide receptor agonists (GLP-1RAs) or glucose-dependent insulinotropic polypeptide/glucagon-like peptide receptor agonists (GIP/GLP-1RAs) clinical interventions
"In 2023, it is estimated that 500,000 people consumed one of these drugs in the US, and it is estimated that it could reach up to 15 million American adults by 2030
Medical supervision means dose titration, side-effect management and regular check-ins not a prescription mailed from an anonymous website
This guide breaks down exactly what happens after your first dose, hour by hour, day by day, and week by week, so you know precisely what to expect and when to expect it
Branded Medications Ozempic and Wegovy are trademarked branded medications that are FDA-approved for specific uses, such as type 2 diabetes and chronic weight management